The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies

As many patients ultimately relapse after chimeric antigen receptor (CAR) T-cell therapy, identification of alternative targets is currently being evaluated. Substantial research efforts are underway to develop new targets. The transferrin receptor (TfR) is prevalently expressed on rapidly prolifera...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zilong, Zhang, Yirui, Fu, Mingpeng, Zhao, Liang, Wang, Zhen, Xu, Zhuoshuo, Zhu, Huifen, Lan, Xiaoli, Shen, Guanxin, He, Yong, Lei, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039461/
https://www.ncbi.nlm.nih.gov/pubmed/33854512
http://dx.doi.org/10.3389/fimmu.2021.652924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039461/
https://www.ncbi.nlm.nih.gov/pubmed/33854512
http://dx.doi.org/10.3389/fimmu.2021.652924

Ejemplares similares